Please Wait...

Molecular Marker Lab

Specialized biomarker services backed by unrivalled scientific expertise, fully validated technology and the highest quality standard.

Molecular Marker Lab - Highly Specialized Biomarker Services for Clinical Trials

Bioclinica Lab is a highly specialized service provider of biochemical marker analysis to the pharmaceutical and biotech industries. Our extensive panel of validated biomarkers serve as surrogate endpoints in support of global, multi-site, clinical trials – from phase I to IV – across a wide range of therapeutic areas. With over 15 years of experience, over 400 clinical trials supported, and over 1 million samples analyzed, we are committed to providing quality services for your clinical study.

BIOMARKER MENU

View our complete list of validated Biomarker assays.
LEARN MORE

BIOMARKER ANALYSIS

Automated methods for Biomarker detection and analysis.
LEARN MORE

CLINICAL LAB SERVICES

In house scientific and technical expertise.
LEARN MORE

QUALITY ASSURANCE

Rigorous QA and CAP accreditation.
LEARN MORE

ADDITIONAL RESOURCES

Biomarker Menu

Download MENU

Molecular Marker Laboratory Services

Download Brochure

Alzheimer's Disease Biomarker Lab Expertise

Download Info Sheet

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

NJ Statewide Career & Internship Fair is Friday, April 28! Talk w @BioclinicaJobs Proj Mgmt, BD, CDM, IT. Details… https://t.co/27LdT00OEo
bioclinica (3 hours ago)
eHealth Solutions president Mukhtar Ahmed is speaking at #Phorum17 on Apr. 27 https://t.co/OaBPodxZBF https://t.co/VO6GKV0a8v
bioclinica (4 hours ago)
Global Head of Risk-Based Monitoring Kristin Mauri on #RBM essential capabilities. Read the blog here https://t.co/z3yUGZqOzH
bioclinica (9 hours ago)
Guest column by Nancy Bradish Myers & Anne McNickle on the White House deregulatory landscape @MedDeviceOnline… https://t.co/LlCJtAPpWz
bioclinica (9 hours ago)
Kicking off day 2 Clinical Trial Innov. Summit! Patient recruitment, RBM, technology-enabled #ClinicaTrials r hot t… https://t.co/IoynV539R9
bioclinica (11 hours ago)
Join us in Philly nxt wk at #Biomarkers & Immuno #Oncology World Congress! Happy to answer Qs in any of these areas https://t.co/fJ5mVAfQTe
bioclinica (Yesterday)

Latest Blogs: